| AKT | protein kinase B |
| AXL | anexelekto |
| ABCB1 | ATP-binding cassette subfamily B member 1 |
| BRAF | B-Raf proto-oncogene, serine/threonine kinase |
| BCL-2 | B-cell lymphoma 2 |
| BIM | Bcl-2 Interacting Mediator of Cell Death |
| C797S | cysteine 797 to serine (mutation in EGFR) |
| CDK4/6 | cyclin-dependent kinases 4 and 6 |
| CEP7 | chromosome enumeration probe 7 |
| CNS | central nervous system |
| CTNNB1 | catenin beta 1 |
| CAFs | cancer-associated fibroblasts |
| cGAS–STING | cyclic GMP-AMP synthase–stimulator of interferon genes |
| c-MET | mesenchymal–epithelial transition factor |
| EGFR | epidermal growth factor receptor |
| EMT | epithelial–mesenchymal transition |
| ERK | extracellular signal-regulated kinase |
| EMT-TFs | epithelial–mesenchymal transition transcription factors |
| FGFR1 | fibroblast growth factor receptor 1 |
| FOXP | forkhead box P |
| GSK-3β | glycogen synthase kinase 3 beta |
| HER2 | human epidermal growth factor receptor 2 |
| HER3 | human epidermal growth factor receptor 3 |
| HGF | hepatocyte growth factor |
| HER3-DXd | HER3-directed DXd conjugate |
| IGF1R | insulin-like growth factor 1 receptor |
| IL-6 | interleukin 6 |
| IL-12 | interleukin 12 |
| JAK | Janus kinase |
| KRAS | Kirsten rat sarcoma viral oncogene homologue |
| L792H | leucine 792 to histidine (mutation in EGFR) |
| MAPK | mitogen-activated protein kinase |
| MERTK | proto-oncogene tyrosine-protein kinase MER |
| MET | mesenchymal–epithelial transition factor |
| MCL1 | myeloid cell leukemia 1 |
| NSCLC | non-small-cell lung cancer |
| NRAS | neuroblastoma RAS viral oncogene homologue |
| NOX | NADPH oxidase |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| ORR | overall response rate |
| OS | overall survival |
| PD-L1 | programmed death-ligand 1 |
| PFS | progression-free survival |
| PI3K | phosphoinositide 3-kinase |
| PLK1 | polo-like kinase 1 |
| PTEN | phosphatase and tensin homologue |
| PARP | poly(ADP-ribose) polymerase |
| PD-1 | programmed cell death protein 1 |
| RAF | rapidly accelerated fibrosarcoma |
| RAS | rat sarcoma viral oncogene |
| RB1 | retinoblastoma 1 |
| RTK | receptor tyrosine kinase |
| RT | radiation therapy |
| SMAD2 | mothers against decapentaplegic homologue 2 |
| STAT | signal transducer and activator of transcription |
| STAT3 | signal transducer and activator of transcription 3 |
| T790M | threonine 790 to methionine (mutation in EGFR) |
| TGFβ | transforming growth factor beta |
| TME | tumor microenvironment |
| TKI | tyrosine kinase inhibitor |
| TAM | tumor-associated macrophage |
| TARO3 | tyrosine-protein kinase receptor 3 |
| T-DM1 | trastuzumab emtansine |
| VEGF | vascular endothelial growth factor |
| VEGFR | vascular endothelial growth factor receptor |
| ZEB | zinc finger E-box binding homeobox |